Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
10/26/2022
CDE Solicits Comments on Draft Technical Guidelines for Clinical Trial...
10/19/2022
The Emergence of Commercial Health Insurances as An Access Route to th...
10/12/2022
Cracking the Code to Commercial Promise in Asia (PharmExec)
10/9/2022
CDE Solicits Comments on Draft Technical Guidelines for Clinical Trial...
10/6/2022
AIM Vaccine Launches IPO on the Main Board of SEHK
10/6/2022
Telemedicine Expanded to Rural China: Across the Divide
10/4/2022
Moderna Refuses Chinese Request to Hand Over mRNA Technology, Risking ...
9/28/2022
Qiming Venture: 'Overinvested' China Healthcare Sector Set for Shake U...
9/27/2022
Legend's Carvykti Wins Japanese Approval for Relapsed or Refractory M...
9/22/2022
Moderna 'Eager' to Collaborate with China on Supplying COVID Vaccines
9/16/2022
Competition Intensifies as More Chinese Regions Embarks on Free HPV Va...
9/2/2022
SAMR Issues New Regulation on Online Drug Sales (with Summary)
8/31/2022
BCG Report: Chinese Vaccine Sector under Restructure - Opportunities a...
8/24/2022
Chinese Vaccine Regulatory System Passes New WHO Assessment for ML3 Ra...
8/24/2022
Four Publicly Traded Drugmakers Saw Huge Investments in July
8/17/2022
Menarini and SciClone Enter License Pact for Vaborem in China for An...
8/9/2022
Analysis of Regulations for Approval of Digital Therapeutics in China
8/2/2022
China Slaps MAH System on Vaccine Manufacturing to Limit Newcomers (Ph...
7/26/2022
Mobile Health Applications for Depression in China: A Systematic Revie...
7/22/2022
Two Chinese Biotechs Raise Millions for Shingles Vaccine Candidates to...
7/18/2022
Pharmanovia Expands Its Footprint in China With The Acquisition of Roc...
7/18/2022
Unicycive Enters License Deal with Lee's Pharma for Renazorb in China ...
7/18/2022
Chugai's Osteoporosis Agent Edirol Launched in China
7/13/2022
Korea's Orion Holdings Agrees to Build A Tuberculosis Vaccine Plant in...
7/8/2022
Asia's Rise in The Global Pharma Industry (PharmExec)
7/5/2022
Biotech Winter in China Set to Adjust Valuation and Prompt Consolidati...
6/29/2022
Nature: Unleashing the Power of Big Data to Guide Precision Medicine i...
6/27/2022
NMPA Issues Three New Documents on Drug Tracing and Vaccine Production...
6/21/2022
Xuanzhu Biopharma Out-licenses Greater China Rights of Two Anti-infect...
6/18/2022
Understanding China's Internet Healthcare and Opportunities for Invest...
Page:
5
/
68
Total number of articles:
2025
:
[First]
[<<]
[3]
[4]
[5]
[6]
[7]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit